hotspot -WSS

hotspot

author：knowledge 2025-09-30 17:28:57 - browse：4

A sign of Gilead Sciences sits in front of its headquarter and next to a pedestrian crossing sign — health coverage from STAT — Justin Sullivan/Getty Images

The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate Division of California Appeals held that companies not only have to defend products they have developed and marketed, but also those they have not.

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage. In the years that followed, the company invested in research leading to additional TDF-based regimens critical to the fight against HIV. It had also done preliminary work on a similar but different drug — tenofovir alafenamide fumarate (TAF) — for which it had early, although not definitive, evidence for safety and efficacy.

Ultimately, this medicine was shown to have a better side effect profile than TDF. Starting in 2018, plaintiffs began suing Gilead for negligently failing to develop TAF earlier, on the theory that it wanted to protect the profits from TDF. Now, the California court has agreed to let the suit proceed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Albert Bourla of Pfizer: worst biopharma CEO of 2023

explore

WSS

Amazon on where the company's health care bets are headed next

How to protect patients from sexual assault

The 10 drugs up first for Medicare price negotiation

'Make People Better': The CRISPR babies story you probably don't know

Three trends to watch in biotech in 2024

SEC charges former device maker CEO with $41 million fraud

entertainment

hotspot

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AstraZeneca chief proposes a novel edit to the drug pricing bill

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why health care costs have stayed mostly flat since 2010

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Amazon on where the company's health care bets are headed next

In Memoriam: Notable people who died in 2023

Why health care costs have stayed mostly flat since 2010

hotspot

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

NIH nominee Bertagnolli will get October confirmation hearing

Hospitals owned by private equity see complications spike 25%

SEC charges former device maker CEO with $41 million fraud

Why health records don't always know when patients are dead

Violet CEO on training clinicians to promote more inclusive care

knowledge

explore

explore

hotspot